
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.1902 | -47.2301587302 | 2.52 | 2.74 | 1.265 | 27369621 | 1.89353676 | CS |
4 | 0.9137 | 219.586637827 | 0.4161 | 2.74 | 0.3546 | 42541000 | 1.32870493 | CS |
12 | 0.5662 | 74.148768989 | 0.7636 | 2.74 | 0.3546 | 14846456 | 1.27758987 | CS |
26 | 0.3698 | 38.5208333333 | 0.96 | 2.74 | 0.3546 | 6769282 | 1.26411225 | CS |
52 | -2.8302 | -68.0336538462 | 4.16 | 4.74 | 0.3546 | 3687166 | 1.36656153 | CS |
156 | -3.3702 | -71.7063829787 | 4.7 | 5.195 | 0.3546 | 1830597 | 1.64327408 | CS |
260 | -3.3702 | -71.7063829787 | 4.7 | 5.195 | 0.3546 | 1830597 | 1.64327408 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約